Pivotal Therapeutics Stock Price (OTCMKTS:PVTTF)

Add to My Stocks
$0 $0 (0%) PVTTF stock closing price Sep 17, 2018 (Closing)
Prev Close* : $0
Market Cap:
$0.04M
Day Low: $0
52 Week Low: $0.00
Open: $0
Volume: $0
Day High: $0
52 Week High: $0.01
Dividend:
0.00

Latest Stock Market News

Latest Articles

PVTTF Stockcharts

View PVTTF PE ratio, PS ratio stocks charts and compare with peers.
PVTTF Chart
Note: Compare Pivotal Therapeutics stock price history with the index and industry peers.

Pivotal Therapeutics Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Pivotal Therapeutics Returns

ROE
(return on equity)

Pivotal Therapeutics Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

PVTTF Industry Peers

Company Price Change (%)
Curaxis Pharma (CURXQ)00 (0%)
Inspyr Therptcs (NSPX)0.010 (0%)
Telesta Therapeutics (BNHLF)0.10 (0%)
Acerus Pharma (TRLPF)0.210.03 (16.67%)
Pivot Pharma (PVOTF)1.050.54 (105.88%)
Aralez Pharma (ARLZQ)0.020.01 (33.33%)
Concordia International (CXRXD)18.80.33 (1.79%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Neptune Tech. & Bio. (NEPT)4.210.39 (10.21%)
Rigel Pharma (RIGL)3.410.2 (6.23%)
Galectin Therapeutics (GALT)5.740.32 (5.9%)
Ionis Pharma (IONS)48.192.19 (4.76%)
Spectrum Pharma (SPPI)20.130.55 (2.81%)
Corcept Therapeutics (CORT)14.740.35 (2.43%)
Grifols (GRFS)20.420.35 (1.74%)
Top gainers from Medical-Drugs industry
* As of Sep 18, 2018
CompanyPriceChange (%)
Recro Pharma (REPH)7.70.86 (10.05%)
CASI Pharma (CASI)5.630.59 (9.49%)
Achaogen (AKAO)4.110.36 (8.05%)
ArQule (ARQL)5.040.43 (7.86%)
CORREVIO PHARMA (CORV)4.30.33 (7.13%)
Ironwood Pharma (IRWD)17.091.18 (6.46%)
Aerie Pharma (AERI)56.153 (5.07%)
Top losers from Medical-Drugs industry
* As of Sep 18, 2018

Pivotal Therapeutics Financial Statements

income statement2014201320122011
Net Sales or Revenues----
Net Income4.87M-2.87M-3.61M-3.84M
Total Operating Expense4.35M2.43M3.15M3.81M
View Pivotal Therapeutics income statement
balance sheet2014201320122011
Total Assets1.98M1.95M1.77M3.4M
Total Liabilities6.01M2.54M--
Shareholders Equity-4.03M-0.59M1.01M3.11M
View Pivotal Therapeutics balance sheet
cash flow statement2014201320122011
Net Increase (Decrease) in Assets Liabilities-0.21M-0.05M--1.03M
Net Cash from (used by) Operating Activities-4.14M-2.57M-3M-3.25M
Increase (Decrease) in Prop Plant And Equipment-0.37M-0.01M-0.05M-0.04M
View Pivotal Therapeutics cash flow statement

Pivotal Therapeutics Stock Message Board

Pivotal Therapeutics stock price ended the last trading day at $0. Pivotal Therapeutics market capitalization is $0.04M and it represents the total market value of PVTTF stock. Pivotal Therapeutics valuation can be guaged using various valuation metrics like the price to earnings ratio.

For recognizing and analyzing the real performance of Pivotal Therapeutics stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume number in Pivotal Therapeutics stock quote data shows the number of shares traded. For Ex: 0 Pivotal Therapeutics shares were traded as of last trading day, as seen from Pivotal Therapeutics stock chart. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Pivotal Therapeutics does not pay dividends. One can observe stock price trends and check for volatility by checking Pivotal Therapeutics stock price history.

Related to Pivotal Therapeutics Stock Quotes

Stocks from Medical-Drugs, Pivotal Therapeutics stock price history,